Chuck Royce started to build up the position in Mirati Therapeutics in Q1 2017 and continued to invest until Q2 2017. Since then they sold 251 Thousand shares. The investor completely sold their stake between Q4 2017 and Q2 2019.
Avg closing price
Price range
Sold -20 Thousand shares
Q2 2019
Avg closing price
$77.85
Price range
$59.49
-
$104.71
Sold 35.7% shares (-11.1 Thousand shares)
Q1 2019
Avg closing price
$68.03
Price range
$43.65
-
$78.95
Sold 39.1% shares (-20 Thousand shares)
Q3 2018
Avg closing price
$55.67
Price range
$47.10
-
$62.70
Sold 16.4% shares (-10 Thousand shares)
Q2 2018
Avg closing price
$37.77
Price range
$26.05
-
$52.40
Sold 49.5% shares (-60 Thousand shares)
Q1 2018
Avg closing price
$27.76
Price range
$17.20
-
$34.95
Sold 51.8% shares (-130 Thousand shares)
Q4 2017
Avg closing price
$15.52
Price range
$12.65
-
$19.00
Increased shares by 88.7% (+118 Thousand shares)
Q2 2017